Draw
|
Currency :
Structure Search
AG003QYP
135-09-1 | 6-(Trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
![Chemical structure of 6-(Trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide, CAS 135-09-1](https://api.angenesci.com/structure/4019/135-09-1.png)
AG003QYP
SDS
COA
Add to Cart
Request For Quotation
- mg
- g
- kg
- ml
- L
无数据
无数据
- mg
- g
- kg
- ml
- L
无数据
| CAS Number | 135-09-1 |
| Catalog Number | AG003QYP(AGN-PC-0PKHEB) |
| Chemical Name | 6-(Trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide |
| EC Number | 205-173-8 |
| IUPAC Name | 1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide |
| InChI | InChI=1S/C8H8F3N3O4S2/c9-8(10,11)4-1-5-7(2-6(4)19(12,15)16)20(17,18)14-3-13-5/h1-2,13-14H,3H2,(H2,12,15,16) |
| InChI Key | DMDGGSIALPNSEE-UHFFFAOYSA-N |
| MDL Number | MFCD00057316 |
| Molecular Formula | C8H8F3N3O4S2 |
| Molecular Weight | 331.2920 |
| SMILES | O=S1(C2=C(C=C(C(F)(F)F)C(S(N)(=O)=O)=C2)NCN1)=O |
| UNII | 501CFL162R |
| Synonyms | Diucardin,
Hydroflumethiazide,
Trifluoromethylhydrothiazide,
hydroflumethiazide,
135-09-1,
Hidroflumetiazid,
Diuredemina,
Glomerulin,
Hydroflumethizide,
Diurometon,
Flutizide,
Hidroalogen,
Spandiuril,
Robezon,
Saluron,
Enjit,
Trifluoromethylhydrothiazide,
Bristurin,
Diucardin,
Elodrine,
Hydrenox,
Leodrine,
Olmagran,
Rodiuran,
Vergonil,
Bristab,
Finuret,
Rontyl,
Sisuril,
Hydol,
NaClex,
Di-ademil,
Dihydroflumethazide,
Dihydroflumethiazide,
Trifluoromethylhydrazide,
Hydroflumethazide,
Elodrin,
Hidroflumetiazida,
Metforylthiadiazin,
Hydroflumethiazidum,
Metflorylthiazidine,
Methforylthiazidine,
Rivosil,
Idroflumetiazide,
Di-adenil,
Metforylthiazidin,
Naciex (glaxo),
6-(Trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide,
Idroflumetiazide [DCIT],
component of Salutensin,
Hidroflumetiazida [INN-Spanish],
Hydroflumethiazidum [INN-Latin],
NSC 44627,
UNII-501CFL162R,
C8H8F3N3O4S2,
HSDB 3340,
6-Trifluoromethyl-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide,
6-(Trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,
EINECS 205-173-8,
BRN 0342692,
3,4-Dihydro-6-trifluoromethyl-7-sulfamoylbenzo-1,2,4-thiadiazine 1,1-dioxide,
3,4-Dihydro-7-sulfamyl-6-trifluoromethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide,
6-Trifluoromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide,
7-Sulfamyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide,
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide,
MLS000028516,
CHEBI:5784,
501CFL162R,
NSC44627,
7-Sulfamyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1, 1-dioxide,
3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,
NCGC00016401-01,
CAS-135-09-1,
SMR000058284,
DSSTox_CID_3132,
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide,
DSSTox_RID_76886,
DSSTox_GSID_23132,
3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulphonamide-1,1-dioxide,
3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiadiazine-7-sulphonamide-1,1-dioxide,
6-(Trifluoromethyl)-3,4-dihydro-2H-benzo-[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide,
Saluron (TN),
Hydroflumethiazide [INN:BAN:JAN],
SR-01000003094,
River,
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1?^{6},2,4-benzothiadiazine-7-sulfonamide,
Hydroflumethiazide (JAN/USP/INN),
Prestwick_268,
Hydroflumethiazide [USP:INN:BAN:JAN],
Spectrum_000905,
Opera_ID_326,
AC1L1GEH,
AC1Q4JYO,
Prestwick0_000013,
Prestwick1_000013,
Prestwick2_000013,
Prestwick3_000013,
Spectrum2_001010,
Spectrum3_000460,
Spectrum4_000010,
Spectrum5_000832,
cid_3647,
CHEMBL1763,
SCHEMBL27028,
BSPBio_000045,
BSPBio_002140,
KBioGR_000359,
KBioSS_001385,
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1,
4-27-00-08035 (Beilstein Handbook Reference),
MLS001148090,
DivK1c_000512,
SPECTRUM1500341,
BMCL182567 Compound 6b,
SPBio_001139,
SPBio_001966,
BPBio1_000051,
GTPL7197,
DTXSID3023132,
BDBM25897,
CTK8C4452,
HMS501J14,
KBio1_000512,
KBio2_001385,
KBio2_003953,
KBio2_006521,
KBio3_001360,
DMDGGSIALPNSEE-UHFFFAOYSA-N,
NINDS_000512,
3,2,4-thiadiazine 1,1-dioxide,
HMS1568C07,
HMS1920F05,
HMS2091L13,
HMS2095C07,
HMS2235E09,
HMS3259C15,
HMS3371H03,
HMS3712C07,
Pharmakon1600-01500341,
ZINC897225,
ZX-AP007542,
Tox21_110422,
6273AA,
ANW-72013,
CCG-40228,
MFCD00057316,
NSC-44627,
NSC757071,
PC0903,
3,2,4-benzothiadiazine 1,1-dioxide,
6-Trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide,
7-Sulfamoyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide,
AKOS015913797,
Tox21_110422_1,
DB00774,
MCULE-8204847370,
NC00496,
NSC-757071,
VZ25545,
2H-1,2, 4-Benzothiadiazine-7-sulfonamide, 3, 4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide,
3, 4-Dihydro-6-trifluoromethyl-7-sulfamoylbenzo-1,2,4-thiadiazine 1, 1-dioxide,
3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,
3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide,
6-Trifluoromethyl-3, 4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide,
6-Trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2, 4-benzothiadiazine-1,1-dioxide,
IDI1_000512,
NCGC00016401-02,
NCGC00016401-03,
NCGC00016401-04,
NCGC00016401-05,
NCGC00016401-06,
NCGC00016401-09,
NCGC00023353-03,
NCGC00023353-04,
AJ-24271,
CC-13172,
CPD000058284,
LS-40451,
SAM002703134,
WLN: T66 BSWM EM DHJ HXFFF ISZW,
ZB015131,
SBI-0051411.P003,
AX8006313,
DB-042267,
TC-160758,
AB00052016,
FT-0614319,
Hydroflumethiazide, analytical standard, ~97%,
C07763,
D00654,
AB00052016_15,
A806882,
C-20051,
3,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide,
J-006640,
SR-01000003094-2,
SR-01000003094-3,
SR-01000003094-5,
6-Trifluoromethyl-3,2,4-benzothiadiazine 1,1-dioxide,
BRD-K36862742-001-05-8,
BRD-K36862742-001-15-7,
BRD-K36862742-001-24-9,
I14-45008,
6-Trifluoromethyl-7-sulfamoyl-3,2,4-benzothiadiazine-1,1-dioxide,
7-Sulfamoyl-6-trifluoromethyl-3,2,4-benzothiadiazine 1,1-dioxide,
Hydroflumethiazide, United States Pharmacopeia (USP) Reference Standard,
1,1-Dioxo-6-(trifluoromethyl)-1,2,3,4-tetrahydro-2,4-benzothiadiazine-7-sulfonamide,
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide,
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6,2,4-benzothiadiazine-7-sulfonamide,
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-16,2,4-benzothiadiazine-7-sulfonamide,
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide,
2H-1,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide,
3, 4-Dihydro-6-trifluoromethyl-2H-1,2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide,
3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide,
3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiadiazine-7sulphonamide-1,1-dioxide,
3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2, 4-benzothiadiazine 1,1-dioxide,
6-(Trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #,
7-Sulfamoyl-6-trifluoromethyl-3, 4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide,
1,1-bis(oxidanylidene)-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide,
1,1-DIOXO-6-(TRIFLUOROMETHYL)-1,2,3,4-TETRAHYDRO-1L-6-2-4-BENZATHIADIAZINE-7-SULFONAMIDE,
Salutensin,
Salutensin-Demi,
Mixture Name,
7-Sulfamoyl-6-tri,
adiazine 1,1-dioxide,
D00WAM,
3, 4-Dihydro-6-trifluorom,
CID3647,
Hydroflumethiazide [BAN:INN:JAN],
AR-1J2060,
C8-H8-F3-N3-O4-S2,
HYDROFLUMETHIAZIDE AND RESERPINE,
RESERPINE AND HYDROFLUMETHIAZIDE,
CS-O-01629,
SB01887,
3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2, 4-benzothi,
ethyl-2H-1,2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide,
fluoromethyl-3, 4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide,
HFZ,
1,1-Dioxo-6-(trifluoromethyl)-1,2,3,4-tetrahydro-1lambda~6~,2,4-benzothiadiazine-7-sulfonamide,
958-92-9,
|
| Complexity | 578 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 330.991g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 20 |
| Hydrogen Bond Acceptor Count | 10 |
| Hydrogen Bond Donor Count | 3 |
| Isotope Atom Count | 0 |
| Molecular Weight | 331.284g/mol |
| Monoisotopic Mass | 330.991g/mol |
| Rotatable Bond Count | 1 |
| Topological Polar Surface Area | 135A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 0.4 |
GHS Hazard and Precautionary Statements
| Symbol: |  |
| Hazard Class | |
| Hazard statements | H302-H315-H319-H335 |
| Packing Group | |
| Precautionary statements | P261-P305+P351+P338 |
| UN Code |
Certificate of Analysis
Lot Number
Related Research Chemicals
CERTIFICATE OF ANALYSIS
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
Analysis Data:
| Test: | Result: |
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited